Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
• Multiple clinical milestones achieved including the first proof-of-concept for DMT-based therapies from a blinded placebo-controlled study • Preliminary findings from SPL028 Phase I clinical trial support target drug profile • O...
5 new patent grants, 3 expected upcoming patent grants, and 8 notices of allowance in key international jurisdictionsLONDON, May 25, 2023 -- Small Pharma Inc. , a biotechnology company focused on... | May 25, 2023
5 new patent grants, 3 expected upcoming patent grants, and 8 notices of allowance in key international jurisdictions...
Small Pharma Inc. (CVE:DMT – Get Rating)’s share price shot up 7.1% on Wednesday . The company traded as high as C$0.08 and last traded at C$0.08. 102,000 shares traded hands during trading, a decline of 57% from the average session volume of 239,262 shares. The stock had previously closed at C$0.07. Small Pharma Stock […]
Small Pharma Inc. (OTCMKTS:DMTTF – Get Rating) was the recipient of a significant decline in short interest in April. As of April 30th, there was short interest totalling 130,700 shares, a decline of 22.5% from the April 15th total of 168,700 shares. Based on an average daily volume of 122,300 shares, the short-interest ratio is […]